KARA PARKER: Open Payments
NPI 1861855751 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,923 in 116 payments from 24 companies in 2025. Trend: 2023 $1,866 · 2024 $2,322 · 2025 $2,923
Food & beverage: $2,923
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 28 | $691 |
| Endo USA, Inc. | 19 | $447 |
| Astellas Pharma US Inc | 13 | $334 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $258 |
| Janssen Biotech, Inc. | 10 | $209 |
| Medtronic, Inc. | 1 | $165 |
| ABBVIE INC. | 6 | $149 |
| Teleflex LLC | 3 | $79 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Ferring Pharmaceuticals Inc. | 3 | $71 |
Products named: GEMTESA, Xtandi, Nubeqa, XIAFLEX, AVEED, ERLEADA, INTERSTIM, BOTOX.
Industry payments across VA — which companies pay providers there.
